title: Why The Narrative Around J&J Is Shifting Amid Analyst Upgrades and Pharma Developments
source: Yahoo
date: 2025-10-08
url: https://finnhub.io/api/news?id=bfe65b4ac0d8a8cadb5f78429819837869dad9321f8b069211fecca762a91b1e
Johnson & Johnson stock has recently seen its consensus analyst price target lifted from $179.64 to $185.13, marking an increase of approximately $5.49 as market sentiment improves. This upward revision comes as analysts anticipate renewed growth and express confidence in Johnson & Johnson's strategic direction, following noteworthy developments in its Pharma segment. Stay tuned to discover how you can stay informed and ahead as the story surrounding Johnson & Johnson's evolving narrative...
